ZE74-0022

N/A

Report date: 2025/10/29 17:56:16
NME

Base Information

Drug NameZE74-0022
Drug Alias NameZE74-0022
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesBarinthus Biotherapeutics PLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A